Vaccines against Flaviviruses and Alphaviruses: Recent Advances and Future Challenges—2nd Edition
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against Tropical and other Infectious Diseases".
Deadline for manuscript submissions: 31 August 2025
Special Issue Editors
Interests: plasmodium vivax; pre-erythrocytic malaria vaccines; flavivirus vaccines; alphavirus-based vaccines; zika vaccines; dengue vaccines; chikungunya vaccines; VLP; recombinant viral vectors; chimpanzee adenovirus (ChAdOx); MVA
Special Issues, Collections and Topics in MDPI journals
Interests: alphaviruses; flaviviruses; bacteria; vaccines; diagnostics; immunology; immunoassays
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mosquito-borne viruses, such as Dengue (DENV), Zika (ZIKV), and Chikungunya (CHIKV) viruses, have emerged in recent decades, affecting millions of people worldwide. These flaviviruses and alphaviruses can be classified into a broader category of arboviruses, and they cause significant disease burdens and public health concerns. Vaccine development against arboviruses has experienced swift progress after the sudden (re)emergence of cases of DENV, CHIKV, and ZIKV in the last two decades. A wide range of vaccine platforms, including both classical and new approaches, such as inactivated and attenuated, proteins, virus-like particles (VLPs), viral vectors, DNA, and mRNA, are currently being tested in preclinical studies and in clinical trials, which could lead to the future licensing of vaccines against these arboviruses.
This Special Issue is based on vaccines against flaviviruses and alphaviruses of medical importance in humans, with particular focus on the design, development, and validation of new vaccine candidates and animal models. We welcome the submission of all types of articles, including short reports, original research, and reviews for this Special Issue. We look forward to receiving your contributions.
Dr. Young Chan Kim
Dr. Arturo Reyes-Sandoval
Guest Editors
Dr. Arturo Reyes-Sandoval
Dr. Young Chan Kim
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine
- arbovirus
- flavivirus
- alphavirus
- vaccines
- preclinical
- animal model
- challenge studies
- clinical trials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
